Maria Rita Bongiorno

Prof ordinario

Università degli Studi di Palermo

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Cancer Biology Cancer Biology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Maria Rita Bongiorno is a Professor Ordinario at Università degli Studi di Palermo, Italy. Her research focuses on dermatological conditions and cancer, including recent studies on atopic dermatitis treatment, genetic susceptibility to skin cancers, and colorectal cancer stem cell therapies. She has published articles addressing the effects of dupilumab, adherence to biological therapies during the COVID-19 pandemic, and approaches to preventing cancer recurrence.

Articles (9)

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

ITALY

View details

Giuseppina Candore

University of Palermo

ITALY

View details

Stefania Raimondo

University of Palermo

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Maria Rita Bongiorno

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Lengthening the time intervals between doses of dupilumab in remission atopic dermatitis

Dual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem Cells

TGF-β/VEGF-A Genetic Variants Interplay in Genetic Susceptibility to Non-Melanocytic Skin Cancer

Nodular morphea keloidal type: A rare case with paradigmatic histopathology significantly accompanied by a flawless surgical scar

Nobiletin and Xanthohumol Sensitize Colorectal Cancer Stem Cells to Standard Chemotherapy

Our experience with prurigo nodularis treated with dupilumab

Adherence to biological therapy in dermatological patients during the COVID‐19 pandemic in Western Sicily

Possible strategy to prevent recurrence of actinic keratosis after treatment field‐direct

Ocular surface disease during dupilumab treatment in patients with atopic dermatitis, is it possible to prevent it?

Collaborators (8)

Barbara Parrino

Carmine Ostacolo

Giulia Accardi

Miriam GAGGIANESI

Giorgio Stassi

Anna Aiello

Giuseppina Candore

Stefania Raimondo

Make your next move.